Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333122 · ClinicalTrials.gov registry record
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
A clinical trial of Breast Cancer Female, sponsored by Henry Ford Health System.
- Active
- Registry status
- 575
- Enrollment target
- 1
- Study location
NCT03333122 is a study of Breast Cancer Female that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 575 participants, below the 680-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03333122, a study of Breast Cancer Female, is active but no longer recruiting, sponsored by Henry Ford Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 575 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to learn more about the quality of life and satisfaction with breast cancer surgical treatment and education from patient reported outcome data. The data and information obtained from breast cancer patients can be invaluable in counselling patients with a new diagnosis of breast cancer on their expected outcomes and results. The hypothesis is that using prospectively obtained data to guide surgical decision-making and optimize access to surgical procedures would improve the treatment of patients and would most likely positively impact the health-related quality of life in patients.
Conditions Studied
Study Locations (1)
Michigan
- Henry Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 575 participants |
| Start Date | 2017-10-31 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03333122
The ClinicalTrials.gov registry entry for NCT03333122 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 575 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 680-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (15% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 0 interventions.
NCT03333122 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03333122 about?
NCT03333122 is a clinical study titled "Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes". The purpose of the study is to learn more about the quality of life and satisfaction with breast cancer surgical treatment and education from patient reported outcome data. The data and information obtained from breast cancer patients can be invaluable in counselling patients with a new diagnosis of...
What is the current status of trial NCT03333122?
This trial is currently active not recruiting. The enrollment target is 575 participants. The study started on 2017-10-31. Estimated completion is 2030-01.
What conditions does trial NCT03333122 study?
This clinical trial studies the following conditions: Breast Cancer Female.
Who is sponsoring clinical trial NCT03333122?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03333122 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.